Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625. - Boxerman JL; Snyder BS; Barboriak DP; Schmainda KM (Frontiers in oncology, 2023)